HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 172 filers reported holding HAEMONETICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $206,000 | -35.4% | 1,800 | -83.6% | 0.00% | 0.0% |
| Q2 2016 | $319,000 | -96.6% | 11,008 | -95.9% | 0.00% | -97.4% |
| Q1 2016 | $9,423,000 | +7.1% | 269,373 | -1.3% | 0.04% | +5.6% |
| Q4 2015 | $8,801,000 | -35.7% | 272,980 | -35.6% | 0.04% | -39.0% |
| Q3 2015 | $13,694,000 | -39.5% | 423,689 | -22.6% | 0.06% | -31.4% |
| Q2 2015 | $22,632,000 | -47.3% | 547,200 | -42.8% | 0.09% | -54.7% |
| Q1 2015 | $42,981,000 | +2.1% | 956,828 | -15.0% | 0.19% | +6.7% |
| Q4 2014 | $42,102,000 | +1.5% | 1,125,132 | -5.3% | 0.18% | +3.5% |
| Q3 2014 | $41,499,000 | -12.5% | 1,188,415 | -11.5% | 0.17% | -13.1% |
| Q2 2014 | $47,402,000 | -15.4% | 1,343,591 | -21.8% | 0.20% | -20.5% |
| Q1 2014 | $56,007,000 | -29.7% | 1,718,538 | -9.1% | 0.25% | -27.0% |
| Q4 2013 | $79,640,000 | -52.0% | 1,890,342 | -54.5% | 0.34% | -21.1% |
| Q3 2013 | $165,752,000 | +88.4% | 4,156,274 | +95.3% | 0.43% | -9.2% |
| Q2 2013 | $87,997,000 | – | 2,128,100 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |